Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3693356010 | Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
3693357018 | Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
46793201000001119 | Salicylic acid 2% / Mucopolysaccharide polysulphate 0.2% gel | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
75148701000001114 | Salicylic acid 2% / Mucopolysaccharide polysulfate 0.2% gel | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Is a | Salicylic acid product | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Is a | Salicylic acid gel | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has active ingredient | Keratolytic agent | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has active ingredient | Salicylic acid | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Is a | Product containing heparinoid | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Is a | Product containing salicylic acid | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has active ingredient | Heparinoid | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has active ingredient | Topical agent | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has manufactured dose form | Cutaneous AND/OR transdermal dosage form | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has manufactured dose form | Gel | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Is a | Product containing salicylic acid in topical dosage form | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has manufactured dose form | Conventional release cutaneous gel | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has concentration strength denominator unit | gram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has precise active ingredient | Heparinoid | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has basis of strength substance | Heparinoid | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has concentration strength denominator unit | gram | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has concentration strength numerator value | 2 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has precise active ingredient | Salicylic acid | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has basis of strength substance | Salicylic acid | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has concentration strength numerator value | 20 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Is a | Product containing only heparinoid and salicylic acid in cutaneous dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Plays role | Antifungal therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has precise active ingredient | Heparinoid | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has basis of strength substance | Heparinoid | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has precise active ingredient | Salicylic acid | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has basis of strength substance | Salicylic acid | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Plays role | Antivaricose therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has manufactured dose form | Cutaneous dose form | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has active ingredient | Salicylate | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has manufactured dose form | Conventional release cutaneous gel | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Continuous dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | gel.cutaneous ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Topical route | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has active ingredient | Salicylic acid | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Cutaneous | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has active ingredient | Mucopolysaccharide polysulphate | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has manufactured dose form | Gel | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has manufactured dose form | Conventional release cutaneous gel | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has active ingredient | Heparinoid | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has manufactured dose form | Conventional release cutaneous gel | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has specific active ingredient | Mucopolysaccharide polysulfate | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has manufactured dose form | Gel | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has manufactured dose form | Gel | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has specific active ingredient | Salicylic acid | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has specific active ingredient | Mucopolysaccharide polysulphate | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has dispensed dose form | Gel | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Is a | Mucopolysaccharide polysulphate + Salicylic acid | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has specific active ingredient | Mucopolysaccharide polysulfate | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has specific active ingredient | Heparinoid | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Has specific active ingredient | Mucopolysaccharide polysulphate | false | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Heparinoid+salicylic acid 0.2%/2% gel - product | Is a | False | Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Inferred relationship | Existential restriction modifier | |
Movelat gel (Sankyo Pharma UK) | Is a | True | Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Inferred relationship | Existential restriction modifier | |
Movelat Relief gel (Sankyo Pharma UK) | Is a | True | Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Inferred relationship | Existential restriction modifier | |
Salicylic acid 2% / Mucopolysaccharide polysulphate 0.2% gel 80 gram | Is pack of | False | Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Inferred relationship | Existential restriction modifier | |
Salicylic acid 2% / Mucopolysaccharide polysulphate 0.2% gel 40 gram | Is pack of | False | Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Inferred relationship | Existential restriction modifier | |
Salicylic acid 2% / Mucopolysaccharide polysulphate 0.2% gel 100 gram | Is pack of | False | Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Inferred relationship | Existential restriction modifier | |
Movelat gel (PI) (Dowelhurst Ltd) | Is a | True | Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Inferred relationship | Existential restriction modifier | |
Salicylic acid 2% / Mucopolysaccharide polysulphate 0.2% gel 120 gram | Is pack of | False | Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Inferred relationship | Existential restriction modifier | |
Movelat gel (PI) (Waymade Ltd) | Is a | True | Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Inferred relationship | Existential restriction modifier | |
Salicylic acid 2% / Mucopolysaccharide polysulphate 0.2% gel 40 gram | Has VMP | True | Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Inferred relationship | Existential restriction modifier | |
Salicylic acid 2% / Mucopolysaccharide polysulphate 0.2% gel 80 gram | Has VMP | True | Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Inferred relationship | Existential restriction modifier | |
Salicylic acid 2% / Mucopolysaccharide polysulphate 0.2% gel 120 gram | Has VMP | True | Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Inferred relationship | Existential restriction modifier | |
Salicylic acid 2% / Mucopolysaccharide polysulphate 0.2% gel 100 gram | Has VMP | True | Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Inferred relationship | Existential restriction modifier | |
Movelat gel (Necessity Supplies Ltd) | Is a | True | Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Inferred relationship | Existential restriction modifier | |
Salicylic acid 2% / Mucopolysaccharide polysulphate 0.2% gel 125 gram | Has VMP | True | Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Inferred relationship | Existential restriction modifier | |
Movelat gel (Lexon (UK) Ltd) | Is a | True | Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Inferred relationship | Existential restriction modifier | |
Salicylic acid 2% / Mucopolysaccharide polysulphate 0.2% gel (J M McGill Ltd) | Is a | False | Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets